Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC6181277/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC6181277/. The analysis below is for the second page.

Title[redir]:
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program - PMC
Description:
Supplemental Digital Content is available in the text. Keywords: canagliflozin; cardiovascular diseases; diabetes mellitus, type 2; glomerular filtration rate; kidney; renal insufficiency, chronic; sodium glucose cotransporter 2; treatment outcome

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Non-Profit & Charity

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We don’t know how the website earns money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Ncbi.nlm.nih.gov could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

egfr, doi, cardiovascular, kidney, canagliflozin, participants, renal, outcomes, diabetes, disease, data, function, effects, risk, mlmin, baseline, heterogeneity, google, scholar, pubmed, type, placebo, ckd, canvas, outcome, effect, study, program, similar, subgroups, trial, events, levels, adverse, sglt, time, research, chronic, glucose, treatment, figure, pmc, people, analysis, janssen, safety, blood, patients, inhibitors, trials,

Topics {✒️}

supplementary material cir-138-1537-s001 web-based response system empa-reg outcome randomised empa-reg outcome investigators pmc beta search computer-generated randomization schedule empa-reg outcome trial including renin-angiotensin system empa-reg outcome study fatal/nonfatal myocardial infarction end-stage kidney disease urine albumin/creatinine ratio acute dose-dependent decline nonlinear mixed-effect model urinary albumin/creatinine ratio medical research council senior research fellowship glomerular filtration rate similar mixed-effect model blood pressure–lowering agents placebo-controlled trial program blood pressure–lowering effects sas enterprise guide license information pmcid reassessing current limitations [google scholar] 14 systolic blood pressure nonfatal myocardial infarction urinary glucose excretion received unrestricted funding alter glomerular hemodynamics independently adjudicated composites preserved kidney function mixed-effect models academic research organization intensive glucose lowering likelihood ratio test received research support canagliflozin significantly slowed possibly greater benefits cox regression models highly skewed distribution alternative energy substrate manipulating tubuloglomerular feedback south wales sydney bristol-myers squibb proportional hazards model diabetic animal models friedewald wt action publisher site pdf

Questions {❓}

  • Are SGLT2 inhibitors ready for prime time for CKD?
  • Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study?
  • What Are the Clinical Implications?
  • What Is New?

Social Networks {👍}(6)

External Links {🔗}(84)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.66s.